World Vaccine Congress Europe 2023

Name: World Vaccine Congress Europe 2023
Start: 2023-10-16T00:00:00+09:00
End: 2023-10-19T23:59:59+09:00
Location: Fira de Barcelona Monjuic

医療/製薬

2023-10-16から2023-10-19

【ワクチン業界を代表するカンファレンス】

World Vaccine Congressは、ワクチンに特化した北米最大規模のカンファレンスです。基礎研究から商業生産まで、ワクチンのバリューチェーン全体を網羅しています。製薬会社、医療機関からワクチンの流通に関わるすべてのステークホルダーに最新動向を提供しています。World Vaccine Congressはヨーロッパと米東海岸、西海岸で開催されています。

主催者サイトへ

基本情報：

国/地域: スペイン

都市名: バルセロナ

イベントタイプ: カンファレンス

◆主要な登壇者：最新のスピーカーリスト

注目の登壇者2021年

Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines & The Hospital Business Unit, ファイザー/Pfizer
Prakash Bhuyan, MD, Vice President, Head of Infectious Diseases, Clinical Development, アストラゼネカ/Astrazeneca
Thomas Breuer, Senior Vice President, Chief Medical Officer, グラクソ・スミスクライン/GSK Vaccines
Dr Miles Carroll, Head of Research & Development Institute, Public Health England
Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance & Veterinary Products Department, World Organisation for Animal Health
Anthony Fiore, Chief, Epidemiology Research & Innovations Branch, Division of Healthcare Quality Promotion, NCEZID, アメリカ疾病予防管理センター/CDC
Adrian Hill, Director & Professor, ジェンナー研究所/The Jenner Institute – University of Oxford
Josep Jansa, Acting Head of Section Emergency Preparedness & Response Support/Group Leader Response & Emergency Operations, 欧州疾病予防管理センター/European Centre for Disease Prevention & Control

Jeffrey Almond, Former Vice President Discovery Research & Development, サノフィ/Sanofi & Visiting Professor, University of Oxford – Oxford Vaccine Group
Annaliesa Anderson, Chief Scientific Officer, Bacterial Vaccines & The Hospital Business Unit, ファイザー/Pfizer
Philip Beer, Physician Scientist & Precision Oncology Specialist, Sanger Institute
Prakash Bhuyan, MD, Vice President, Head of Infectious Diseases, Clinical Development, アストラゼネカ/Astrazeneca
Berend-Jan Bosch, Associate Professor, ユトレヒト大学/Utrecht University
Thomas Breuer, Senior Vice President, Chief Medical Officer, グラクソ・スミスクライン/GSK Vaccines
Ed Buurman, Director Alliances, CARB-X
Alessandro Carabelli, Research Lead, COVID-19 Genomics UK (COG-UK) consortium
Dr Miles Carroll, Head of Research & Development Institute, Public Health England
Jakob Cramer, Head of Clinical Development, CEPI
Isabel De La Mata, Principal Advisor for Health & Crisis Management, 欧州委員会/European Commission
Antu Dey, Senior Director, Research & Development, International AIDS Vaccine Initiative
Matthew Duchars, Chief Executive Officer, Vaccines Manufacturing & Innovation Centre
Dr Cynthia Dukes, VP, Drug Dev Consulting, ICON Clinical Research
Elisabeth Erlacher Vindel, Head of the Antimicrobial Resistance & Veterinary Products Department, World Organisation for Animal Health
Jose Angel M. Escribano, Chairman of the Board and Chief Scientific Officer, Algenex
Thomas Evans, CSO & Board Director, Vaccitech
Fred Fellouse, Senior Research Associate, University of Toronto, The Donnelly Centre
Anthony Fiore, Chief, Epidemiology Research & Innovations Branch, Division of Healthcare Quality Promotion, NCEZID, アメリカ疾病予防管理センター/CDC
Isabel Frost, Consultant, Vaccines and AMR, 世界保健機関/World Health Organization
Luc Gagnon, Vice President, Vaccine Sciences, Nexelis
Greg Glenn, President, Novavax
John Hammond, Group Leader, Genetics, Genomics, Immunology, パーブライト研究所/The Pirbright Institute
David Hering, Regional President, North America, ファイザー/Pfizer
Adrian Hill, Director & Professor, ジェンナー研究所/The Jenner Institute – University of Oxford
David Hipkiss, Chief Executive Officer, Enesi Pharma Limited
Jason Huang, CEO/CMO, Ascendo Biotech
Randall Hyer, Head of Medical Affairs, モデルナ/Moderna Therapeutics
Juanjo Infante, CEO, Vaxdyn
Josep Jansa, Acting Head of Section Emergency Preparedness & Response Support/Group Leader Response & Emergency Operations, 欧州疾病予防管理センター/European Centre for Disease Prevention & Control
Andreas Kuhn, Senior Vice President & Head of RNA Biochemistry & Manufacturing, BioNTech Ag
Calman Maclennan, Professor of Vaccine Immunology, ジェンナー研究所/Jenner Institute
Dr John Markels, President, メルク/Merck Vaccines
Jean-Cedric Meeus, Chief of Transport, ユニセフ/UNICEF
Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals Bv
Lisa Menning, Technical Officer, Vaccines & Biologicals, 世界保健機関/World Health Organisation
Lyn Morgan Marsden, Senior Director Public Affairs, サノフィパスツール/Sanofi Pasteur
Vish Nene, Co-leader Animal & Human Health program, International Livestock Research Institute
Dr Jan Poolman, Head Bacterial Vaccine Discovery & Early Development, ヤンセンファーマ/Janssen
David Robinson, Deputy Director, CMC Vaccines Development & Surveillance, ビル&メリンダ・ゲイツ財団/The Bill & Melinda Gates Foundation
Matthew Snape, Professor, Oxford Vaccine Group
Erin Spiegel, VP Clinical & Regulatory Affairs, PharmaJet
Stig Tollefsen, Technology Office Lead, CEPI
Jonathan Van-Tam, Deputy Chief Medical Officer, UK Department of Health